top of page
EJW Portrait Left Zoom.jpg

Edwin Wang (Past Advisor)

Mr. Wang’s finance career spans 25+ years of experience as private equity and venture
investor, trusted advisor to family investment offices, private/public energy, industrial, life
sciences and technology companies. He is the founder of Accretive Capital Partners LLC,
one of the earliest direct secondary and co-investment sponsors in middle market private
equity that raised, invested and harvested a top quartile vintage June 2008 secondary
direct investment fund (Accretive Exit Capital Partners LP) whose seasoned LPs included
HarbourVest Partners, Goldman Sachs Vintage Funds and Paul Capital Partners. The
collective investment of $250MM in direct stakes of selected portfolio companies from
Evercore Capital Partners II LP (a vintage 2001 $663MM middle market PE fund)
represented an aligned co-investment recapitalization and liquidity event for Evercore and
for the Accretive consortium an incomparable secondary market entry point into quality
companies in the very eye of the storm during the Great Financial Crisis; including
AlliantGroup (leading R&D tax credit advisory firm) and Mr. Bults Inc. (largest long haul transportation and logistics company in waste management). In 2009 Accretive was tasked by the soon to be defunct Citi Alternatives with restructuring, recapitalizing and liquidating PE asset portfolios (e.g., Apollo Management) in excess of $2B on behalf of Citi Global Private Wealth clients, comprising family offices in London and the Middle East.


Previously, from 2002 to 2007 Accretive led the successful financial restructuring and
liquidation of $450MM in distressed venture portfolio assets and was responsible for value-
added liquidity creation in excess of $200MM in the aftermath of the Dotcom Crash of
2001. In restructuring, recapitalizing and liquidating Zero Stage Capital (notable for its lead
role in the original funding of PerSeptive Biosystems and backing of its founder Noubar
Afeyan PhD, whose enduring contribution to humanity is the iconic Moderna), Mr. Wang as
Managing General Partner and Director/Observer in portfolio companies led the successful
monetized turnaround and engineered structured liquidity events for several dozen portfolio
companies: including OuterLink Corporation ($300MM merger with Digital Angel
Corporation); Imaging Automation, Inc. ($12MM acquisition by Viisage, Inc.); First Service
Networks (co-investor buyout); Intersense, Inc. (company buyback); ViaCell, Inc. ($60MM
IPO underwritten by CSFB and UBS); Aprilis, Inc. ($25MM tender offer by CrossMatch
Technologies, Inc.); Axxis ($5MM acquisition by UCG/OPIS); Fletcher Spaght Ventures,
L.P. (partnership interest buyout by Thomas Weisel Partners); LiveWave ($25MM
acquisition by Smiths Detection Services); WorldWinner Inc. ($30MM acquisition by Fun
Technologies, an affiliate of Liberty Media). These accomplishments were chronicled in
several Harvard Business School case studies and leading financial publications such as
The Deal Magazine.

​

Previously, during an eight year investment banking career Mr. Wang architected the
formation and syndication of $250MM Asia Corporate Partners Fund with China
Development Bank (Taiwan), the first ever China direct institutional investment fund with
notable stakes in Texas Instruments/Acer, Hong Hai Precision (Foxconn) and Taiwan
Semiconductor Manufacturing Co. He began his career at Lehman Brothers as an
institutional capital markets and investment banking associate. Mr. Wang earned his B.A.
in Economics from Columbia University and was a Visiting Fellow in Finance at the MIT
Sloan School of Management and sponsored by the late Nobel laureate in Economics, Dr.
Franco Modigliani.

bottom of page